Literature DB >> 31613607

Bifunctional Au-Fe3O4 Nanoheterodimers Acting as X-ray Protector in Healthy Cells and as X-ray Enhancer in Tumor Cells.

Stefanie Klein1, Matthias Smuda1, Christina Harreiß1, Christina Menter1, Luitpold V R Distel2, Carola Kryschi1.   

Abstract

Bifunctional Au-Fe3O4 nanoheterodimers were synthesized by thermally decomposing Fe(III)oleate on gold nanoparticles followed by functionalizing with tiron, 2,3-dihydroxybenzoic acid, or caffeic acid. These catechol derivatives are antioxidative and thus are predicted to function as superoxide scavengers. In particular, caffeic acid lost its antioxidant capacity, although it was covalently linked through its carboxyl moiety to the Fe3O4 surface. Tiron was shown to bind via its catechol group to the Au-Fe3O4 nanoheterodimers, and 2,3-dihydroxybenzoic was just physisorbed between the oleic acid surface structures. Caffeic-acid stabilized Au-Fe3O4 nanoheterodimers turned out to act as X-ray protector in healthy cells but as X-ray enhancing agents in cancer cells. Furthermore, these functionalized Au-Fe3O4 nanoheterodimers were found to inhibit the migratory capacity of the cancer cells.

Entities:  

Keywords:  2,3-dihydroxybenzoic acid; Au−Fe3O4 nanoheterodimers; caffeic acid; cell migration; radioprotector; radiosensitizer; tiron

Mesh:

Substances:

Year:  2019        PMID: 31613607     DOI: 10.1021/acsami.9b13877

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Caffeic Acid, Quercetin and 5-Fluorocytidine-Functionalized Au-Fe3O4 Nanoheterodimers for X-ray-Triggered Drug Delivery in Breast Tumor Spheroids.

Authors:  Stefanie Klein; Luitpold V R Distel; Winfried Neuhuber; Carola Kryschi
Journal:  Nanomaterials (Basel)       Date:  2021-04-29       Impact factor: 5.076

Review 2.  Gold-based Inorganic Nanohybrids for Nanomedicine Applications.

Authors:  Xianguang Ding; Dan Li; Jiang Jiang
Journal:  Theranostics       Date:  2020-07-02       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.